Literature DB >> 6705709

[Epididymitis. Studies on its etiology and pathogenesis with special reference to Chlamydia trachomatis and Ureaplasma urealyticum].

H C Becker, W Weidner, H G Schiefer, H Brunner, W Krause.   

Abstract

A standardized clinical and microbiological diagnostic examination was conducted on 137 patients with acute or chronic epididymitis (cardinal symptom: painful swelling of the epididymis). Patients with spontaneous secretion from the urethra were examined according to the methods of urethritis diagnosis, patients without it with the four-glass test. Gram-negative bacteria and enterococci were responsible for 27.7% of the infections. Additional tests for Chlamydia trachomatis and mycoplasmas increased the microbiological rate of diagnosis to 65.7%. Demonstration of Ureaplasma urealyticum in significant numbers was always associated with urethritis or prostatitis. Chlamydia trachomatis was demonstrated especially in younger, sexually active men with epididymitis but without accompanying urethritis or prostatitis. The most striking clinical finding was a disturbance in bladder emptying in about one third of all patients with epididymitis, regardless of age.

Entities:  

Mesh:

Year:  1984        PMID: 6705709     DOI: 10.1055/s-2008-1069234

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.

Authors:  E Vieler; C Jantos; H L Schmidts; W Weidner; H G Schiefer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

2.  The role of chlamydiae in epididymitis.

Authors:  M D Melekos; H W Asbach
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

3.  Acute nongonococcal epididymitis. Aetiological and therapeutic aspects.

Authors:  W Weidner; H G Schiefer; C Garbe
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.